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CASE REPORT Open Access
Heparin-induced thrombocytopenia
presenting as splenic hemorrhage
following cardiac surgery: a case report
Joseph Ferry1* , Samuel Youssef2, Pierce Wu2 and Livia Hegerova3
Abstract
Background: Heparin-induced thrombocytopenia with thrombosis (HITT) is a paradoxical prothrombotic
complication of anticoagulant therapy. As many as 3% of patients undergoing cardiac surgery develop clinical HIT
presenting as thrombocytopenia with or without thrombosis within 5–10 days of heparin exposure. Thrombotic
complications associated with HIT carry a mortality rate of 5–10%.
Case presentation: We report a case of atraumatic splenic hemorrhage due to splenic vein thrombosis as the
main indicator of HIT following cardiac surgery in a 62-year-old woman. She presented to the emergency
department on day nine following coronary artery bypass graft surgery with acute weakness, dizziness, and malaise.
Her evaluation in the emergency department found anemia and thrombocytopenia. A coagulation profile revealed
a markedly elevated d-dimer. She underwent a computed tomography scan of the chest, abdomen and pelvis for
suspected bleed and was found to have splenic vein thrombosis, right atrial filling defects consistent with atrial
thrombus and mild to moderate hemoperitoneum. Surgical consultation was obtained due to splenic hemorrhage.
Hematology was consulted on post-operative day 10, however, she unfortunately developed left sided weakness
concerning for stroke. A magnetic resonance imaging scan of the brain demonstrated infarct involving distribution
of the right anterior cerebral artery. A transesophageal echocardiogram demonstrated a large immobile thrombus
within the right atrium with a second, mobile thrombus arising from the left tricuspid valve annulus. Due to a 4Ts
score of 7 and markedly positive platelet factor 4 (PF4) IgG antibody a serotonin release assay was not performed
given the high probability of HIT. She was cautiously treated with bivalirudin and was transitioned to warfarin
anticoagulation. In the following days her platelet count recovered and 3months later a transthoracic
echocardiogram revealed solution of the intracardiac thrombi.
Conclusions: Atraumatic splenic hemorrhage is an unusual presentation of HIT that is reminiscent of the rare
bilateral adrenal hemorrhage due to adrenal necrosis that also occurs in HIT. Alternative anticoagulation is the
mainstay of therapy for HIT despite hemorrhage, given the underlying acquired hypercoagulability. Despite
similarities of the presentation between splenic hemorrhage and bilateral adrenal hemorrhage, splenic hemorrhage
is rarely described in the literature. HIT should be considered in patients presenting with thrombocytopenia
following cardiac surgery.
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Essentials
 HIT-associated antibodies are frequently detected
after cardiac surgery
 We report a case of atraumatic splenic hemorrhage
due to HIT following coronary artery bypass
grafting.
 HIT should be suspected for any patient with
congestive hemorrhage following venous
thrombosis, thrombocytopenia, and recent heparin
exposure
 Hemorrhagic splenic infarction due to splenic vein
thrombosis is reminiscent of bilateral adrenal
hemorrhage (BAH) due to adrenal necrosis seen in
HIT
Background
Heparin-induced thrombocytopenia (HIT) is a complica-
tion of heparin therapy which occurs more commonly in
postoperative than medical patients [1]. Up to 50% of
patients undergoing cardiac surgery develop antibodies
to platelet factor 4 (PF4) complexed to heparin, attrib-
uted to platelet activation and high heparin doses during
cardiopulmonary bypass [2]. Only 1 to 3% of these pa-
tients will develop clinical HIT manifesting with
thrombocytopenia with or without thrombosis [2, 3].
HIT typically presents 5–10 days following exposure to
heparin, often with platelet decline greater than 50% of
baseline and is associated with life and limb-threatening
thrombotic complications. HIT should be suspected in
any patient who has received heparin and develops
thrombocytopenia, given high mortality (5–10%) typic-
ally a result of thrombotic complications [1].
One increasingly recognized and unusual thrombotic
complication that is seen in HIT is adrenal vein throm-
bosis with tissue necrosis leading to bilateral adrenal
hemorrhage (BAH). This congestive hemorrhage follow-
ing venous thrombosis should raise high clinical
suspicion for HIT. We present a case of splenic vein
thrombosis post-cardiac surgery complicated
hemorrhagic infarct, reminiscent of that seen in BAH,
that led to the diagnosis of HIT.
Case presentation
A 62-year-old woman with a history of congestive heart
failure, coronary artery disease, diabetes mellitus type 2,
and recent coronary artery bypass graft (CABG)
presented to the emergency department with acute
weakness, dizziness, and malaise.
Past surgery history was significant for a two-vessel
coronary artery bypass graft involving the left internal
mammary artery to the left anterior descending artery
and the left radial to obtuse marginal artery nine days
prior to presentation. In the perioperative period she
received three heparin boluses at 40u/kg based on a
weight of 66.7 kg as well as a heparin infusion dosed be-
tween 16u/kg/hr-26u/kg/hr. for 3 days. She had no
family history of hematological disorders or hypercoagu-
lability. She was on low-dose aspirin. Her complete
blood count (CBC) was normal prior to CABG including
platelet count of 268 x 10P3P/μL (normal 150–379 x
10P3P/μL) and at hospital discharge was 174 x10P3P/μL
with post-operative hematocrit of 36% (normal 37.5–
51%).
On physical examination she was afebrile, hypotensive
with systolic blood pressure in the 70s, and in rapid
atrial fibrillation with heart rate 120–130 s. She denied
abdominal pain and had a benign abdominal examin-
ation. Laboratory data revealed white blood cell count
10.7 x 10P9/PL (normal 3.4–10.8 x 10P9/PL), hematocrit
19%, and platelet count of 49 x10P3P/μL. Complete
metabolic panel and lactate were normal. Troponin was
elevated at 0.21 ng/mL (normal 0.00–0.07 ng/mL. Chest
x-ray was normal. A limited beside echocardiogram
demonstrated no pericardial effusion. She received intra-
venous fluid resuscitation and transferred to the inten-
sive care unit for further evaluation.
Upon arrival to the intensive care unit, she received 2
units of packed red blood cells with appropriate increase
to hematocrit 25% post-transfusion and 1 unit of plate-
lets with increase to 73 x10P3P/μL. Further laboratory
evaluation was negative for hemolysis with normal lac-
tate dehydrogenase 292 U/L (normal 119–226 U/L) and
haptoglobin 98mg/dL (normal 34–200 mg/dL). A dis-
seminated intravascular coagulopathy (DIC) panel dem-
onstrated d-dimer of > 40.00 μg/ml (normal <=0.49 μg/
ml), normal fibrinogen 214 mg/dL (normal 175–475 mg/
dL), international normalized ratio (INR) 1.4 (normal
0.9–1.1), protime (PT) 16.7 s (normal 12.0–14.4 s), par-
tial thromboplastin time (PTT 37.3 s (normal 22.0–35.0
s), normal thrombin time (TT), and normal red blood
cell morphology.
To evaluate for bleeding, a computed tomography
(CT) angiogram of the chest, abdomen, and pelvis was
ordered and demonstrated filling defects suggestive of
right atrial thrombus, splenic vein.
thrombosis with splenic infarct, and mild to moderate
associated hemoperitoneum. She denied abdominal
trauma. Surgery service was consulted and concerned
about splenic hemorrhage. Hematology was consulted to
evaluate the etiology of spontaneous splenic vein throm-
bosis with associated hemorrhagic infarction.
Unfortunately, on the day of Hematology evaluation
(post-operative day 10) she developed left-sided weak-
ness and balance changes concerning for stroke and an
MRI revealed infarct involving the distribution of the
right anterior cerebral artery. A transesophageal echo-
cardiogram revealed large immobile thrombus in the
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right atrium with a second thrombus adjacent to this
which was mobile and.
arising from the left tricuspid valve annulus, large
thrombus in the left atrial appendage, and absence of a
patent foramen ovale (Fig. 1). She was not a candidate
for thrombolytic therapy due to thrombocytopenia. She
was calculated to have a 4Ts score of 7. A heparin PF4
IgG antibody was.
markedly positive with 3.290 OD. Serotonin release
assay was not performed due to the high probability of
HIT evidenced by the markedly positive PF4 IgG and
4Ts score of 7. Together these predictive tools indicate a
72% likelihood ratio and 99% posttest probability of HIT
[4]. Lower extremity ultrasound was negative for throm-
bosis while upper extremity ultrasound showed cephalic
vein thrombosis. The patient was diagnosed with
heparin-induced thrombocytopenia with thrombosis
(HITT).
Given extensive thrombosis in HIT, anticoagulation
was cautiously started with bivalirudin. Our organization
utilizes direct thrombin inhibitor (DTI) levels to monitor
and adjust bivalrudin dosing. Given the presence of
hemoperitoneum prior to bivalruin dosing, bivalrudin
was started at 10.01 mg/hr. and titrated to 12.012 mg/hr.
based on DTI levels and a dose of 0.13–0.156 mg/kg/hr.
at a weight of 77 kg. DTI levels were maintained at goal
between 60 and 90 s throughout therapy. She remained
clinically stable from the intrabdominal hemorrhage and
transitioned to warfarin anticoagulation. Platelets recov-
ered to 108 x10P3P/μL four days after starting alterna-
tive anticoagulation and greater than 150 x10P3P/μL
nine days after therapy for HITT initiated. The patient
had repeat transthoracic echocardiogram after 3 months
of warfarin anticoagulation with the resolution of intra-
cardiac thrombi. She continues on long-term anticoagu-
lation for atrial fibrillation.
Discussion and conclusions
Heparin-induced thrombocytopenia (HIT) is a paradox-
ical prothrombotic syndrome resulting from exposure to
heparin-containing products [5–8]. HIT-associated anti-
bodies are frequently detected after cardiac surgery [9].
Thrombosis in the setting of HIT is more commonly as-
sociated with the venous system, however, arterial
thrombus formation is more common in patients receiv-
ing heparin for cardiovascular disease [5]. We report a
case of atraumatic splenic hemorrhage due to splenic
vein infarction as the main indicator of the diagnosis of
HIT. The presentation is reminiscent of the rare bilateral
adrenal hemorrhage due to adrenal vein thrombosis that
has been reported in HIT. Given the high mortality of
HIT, as high as 28% in cardiac surgery patients, aware-
ness of these unique presentations is critical for earlier
intervention [10].
HIT should be suspected in any patient who has had
prior heparin exposure who presents with
Fig. 1 Transesophageal Echocardiogram (TEE). White arrow demonstrating immobile right atrial thrombus. Striped arrow demonstrates second
mobile thrombus. Grey arrow demonstrates thrombin strands originating from mobile thrombus
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thrombocytopenia, especially if the fall is greater than
50% of baseline count and whether the nadir remains
within the normal range [6]. Our patient had a high 4 T
score and HIT PF4 antibody OD of 3.2 and new splenic
and atrial thrombosis, confirming a diagnosis of HITT.
Anticoagulation was started with parenteral direct
thrombin inhibitor and transitioned to warfarin once
platelet count was within the normal limit for 2 con-
secutive days. Alternative anticoagulation is the mainstay
of therapy for HITT even in the setting of hemorrhage,
given the underlying acquired hypercoagulability.
A well-documented and increasingly well-recognized
thrombotic complication of HIT is bilateral adrenal
hemorrhage [7]. Clues to this rare complication include
the development of abdominal pain, diarrhea, and fever
which often lead to imaging of the abdomen and revela-
tion of injury to the adrenal glands and is confirmed by
corticotropin-stimulation test [7, 11]. The risk of BAH
in a case study of HIT by Warkentin et. al was 1.6%
[12]. Strong arterial blood supply with a single central
vein makes the.
adrenal glands susceptible to congestive hemorrhage
following venous thrombosis [13]. We hypothesize that
the spleen is at similar risk given it too has a rich arterial
supply and single splenic vein.
A literature review reveals few reported cases of
splenic vein thrombosis with hemorrhagic infarction as a
clinical sequela of HIT. Earlier reports discussed spon-
taneous splenic ruptures occurring on heparin anticoag-
ulants, however did not report on HIT antibody testing
[14–17]. One case report had a very similar presentation
of splenic hematoma after cardiac surgery, with splenec-
tomy pathology showing multiple fibrin thrombi in the
spleen [9]. This pathology confirms our hypothesis of
microthrombi leading to subsequent hemorrhagic con-
version in the spleen, as occurs in BAH.
Early imaging to identify these unusual intra-
abdominal thrombotic complications of HIT is encour-
aged [18]. A case report by Lammering et al. discusses a
case of splenic rupture secondary to splenic vein throm-
bosis resulting from HIT, while the discussion focuses
on the utility of multidetector-.
row computed tomography in the rapid and accurate
diagnosis of HIT related thromboembolic complication.
Lammering et al. describe the case in the setting of non-
specific abdominal pain which differed from our patient
without abdominal pain [19].
Treatment of HIT involves alternative non-heparin
anticoagulation in accordance with published guidelines
including those by the American College of Chest Physi-
cians and the updated American Society of Hematology
Guidelines for Management of Venous Thromboembol-
ism: Heparin-Induced Thrombocytopenia [1, 20]. Despite
hemorrhagic complications such as BAH, or as in our
patient intraabdominal hemorrhage due to splenic in-
farction, treatment is careful anticoagulation given the
underlying etiology for hemorrhage is hypercoagulability.
Multiple cases reports on BAH advocate for prompt ini-
tiation of appropriate anticoagulation to ensure a suc-
cessful outcome [12, 21]. We advocate for a similar
approach to congestive splenic hemorrhage following
splenic vein thrombosis as a consequence of HIT.
This case emphasizes that the diagnosis of HIT should
be considered for patients with unusual intra-abdominal
thrombosis or hemorrhage, especially within the ex-
pected time course following heparin exposure.
Congestive hemorrhage following venous thrombosis,
with recent heparin exposure and declining platelet
count, should raise clinical suspicion of HIT. The diag-
nosis of HIT-induced splenic vein thrombosis and sub-
sequent hemorrhagic infarct mimics the rare bilateral
adrenal hemorrhage due to adrenal vein thrombosis seen
in HIT. Multidetector-row computed tomography
should be considered for the evaluation of thrombo-
embolic sequelae in patients with unexplained anemia or
abdominal pain with suspicion of HITT to exclude ad-
renal or splenic involvement. Alternative anticoagulation
remains the mainstay of therapy.
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